WC
TDAC icon

Wealthspring Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Wealthspring Capital’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-204,690
Closed -$2.16M – 229
2026
Q1 		$2.16M Sell
204,690
-2,540
-1% -$26.8K 0.51% 73
2025
Q4 		$2.17M Hold
207,230
– – 0.51% 73
2025
Q3 		$2.14M Sell
207,230
-2,770
-1% -$28.6K 0.51% 63
2025
Q2 		$2.16M Buy
+210,000
New +$2.13M 0.57% 56

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Kryger Capital
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Meteora Capital
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Alberta Investment Management Corp (AIMCo)
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Wealthspring Capital's TDAC Position: Q2 2026 in Review

Wealthspring Capital sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 204,690 shares — an estimated $2.16M sold.

Wealthspring Capital first reported a position in TDAC in Q2 2025 and held it in 4 quarters. The position peaked at $2.17M in Q4 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Wealthspring Capital reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Wealthspring Capital sold 204,690 Translational Development Acquisition Corp shares in Q2 2026, an estimated $2.16M.
  • Wealthspring Capital first reported a position in Translational Development Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • Wealthspring Capital's Translational Development Acquisition Corp position peaked at $2.17M in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Wealthspring Capital's 13F filing for Q2 2026, filed 15 Jul 2026.